Alignment of Chemogenomic and Functional Genomic screening for target ID

Wed20  Oct03:00pm(30 mins)
Room 3A
Dr Joanna Redmond


The talk will describe our strategy for combining functional genomic and chemogenomic screening approaches to find new targets for drug discovery. GSK’s Chemogenomic screening platform has been re-designed and expanded to facilitate its application, alongside genetic screening, in disease relevant primary cellular systems such as iPSC derived macrophages and T cells. The talk will outline our current chemogenomic capability and our strategy for alignment of this capability with CRIPSR screens to identify tractable, genetically validated targets.

Hosted By

The European Laboratory Research & Innovation Group Our Vision : To provide outstanding, leading edge knowledge to the life sciences community on an open access basis
Event Logo Find us on Facebook Follow us on Twitter

Get the App

Get this event information on your mobile by
going to the appstore or google play and search for 'elrig'
Eventflo Home
copyright ELRIG,, Labhoo Ltd 2003-2021